© 2023 The American Journal of Medicine Blog. All Rights Reserved.
venous thromboembolism
What's New from AJM
Effectiveness and Safety of Rivaroxaban Versus Warfarin in Frail Patients with...
Frailty predicts poorer outcomes in patients receiving anticoagulation. We assessed the effectiveness and safety of rivaroxaban vs warfarin in frail patients experiencing venous thromboembolism.
Methods
Using US MarketScan claims data from January 2012-December 2016, we identified frail patients (using the Johns Hopkins Claims-Based Frailty Indicator score) who had ≥1 primary hospitalization/emergency department visit diagnosis codes for venous thromboembolism, received rivaroxaban or...
LATEST VIDEOS
Are Prisoners Good Hospital Patients?
01:59
Improving Care for Orthopedic Surgery Patients
00:41
Orthopedic Surgery + Internal Medicine Co-Management of Patients
01:28
We Need New Strategies to Prevent Lyme Disease
01:00
Patient Communication Strategies from an Italian Barber
01:00
Effects of Long COVID
00:54
Long COVID Brings Functional Limitations
01:24
Using Pet Scans to Diagnose Infections
00:35
Can We Blame Texting for Our Lack of Empathy?
01:00
GLP-1 + Glucose Blocker: Combo Therapy Improves Weight Loss & More
03:08
Should Statins Be Prescribed for Older Adults?
01:38
Pet Scan CT & Fever of Unknown Origin
02:14